![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PRKAG1 |
Gene summary for PRKAG1 |
![]() |
Gene information | Species | Human | Gene symbol | PRKAG1 | Gene ID | 5571 |
Gene name | protein kinase AMP-activated non-catalytic subunit gamma 1 | |
Gene Alias | AMPKG | |
Cytomap | 12q13.12 | |
Gene Type | protein-coding | GO ID | GO:0000003 | UniProtAcc | P54619 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
5571 | PRKAG1 | LZE4T | Human | Esophagus | ESCC | 9.51e-11 | 2.72e-01 | 0.0811 |
5571 | PRKAG1 | LZE5T | Human | Esophagus | ESCC | 8.27e-07 | 3.99e-01 | 0.0514 |
5571 | PRKAG1 | LZE7T | Human | Esophagus | ESCC | 1.98e-09 | 4.00e-01 | 0.0667 |
5571 | PRKAG1 | LZE8T | Human | Esophagus | ESCC | 7.03e-09 | 2.36e-01 | 0.067 |
5571 | PRKAG1 | LZE20T | Human | Esophagus | ESCC | 3.70e-11 | 1.91e-01 | 0.0662 |
5571 | PRKAG1 | LZE22T | Human | Esophagus | ESCC | 1.38e-04 | 2.72e-01 | 0.068 |
5571 | PRKAG1 | LZE24T | Human | Esophagus | ESCC | 1.78e-27 | 5.63e-01 | 0.0596 |
5571 | PRKAG1 | LZE21T | Human | Esophagus | ESCC | 1.30e-08 | 3.58e-01 | 0.0655 |
5571 | PRKAG1 | LZE6T | Human | Esophagus | ESCC | 4.13e-04 | 2.92e-01 | 0.0845 |
5571 | PRKAG1 | P1T-E | Human | Esophagus | ESCC | 3.93e-13 | 6.72e-01 | 0.0875 |
5571 | PRKAG1 | P2T-E | Human | Esophagus | ESCC | 5.46e-38 | 6.98e-01 | 0.1177 |
5571 | PRKAG1 | P4T-E | Human | Esophagus | ESCC | 6.33e-26 | 5.81e-01 | 0.1323 |
5571 | PRKAG1 | P5T-E | Human | Esophagus | ESCC | 4.38e-03 | 1.46e-01 | 0.1327 |
5571 | PRKAG1 | P8T-E | Human | Esophagus | ESCC | 7.44e-27 | 4.84e-01 | 0.0889 |
5571 | PRKAG1 | P9T-E | Human | Esophagus | ESCC | 1.18e-15 | 2.65e-01 | 0.1131 |
5571 | PRKAG1 | P10T-E | Human | Esophagus | ESCC | 1.20e-27 | 4.85e-01 | 0.116 |
5571 | PRKAG1 | P11T-E | Human | Esophagus | ESCC | 5.69e-12 | 4.24e-01 | 0.1426 |
5571 | PRKAG1 | P12T-E | Human | Esophagus | ESCC | 1.67e-26 | 4.44e-01 | 0.1122 |
5571 | PRKAG1 | P15T-E | Human | Esophagus | ESCC | 7.14e-29 | 5.09e-01 | 0.1149 |
5571 | PRKAG1 | P16T-E | Human | Esophagus | ESCC | 7.03e-31 | 5.50e-01 | 0.1153 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0006913110 | Esophagus | ESCC | nucleocytoplasmic transport | 230/8552 | 301/18723 | 6.04e-28 | 2.02e-25 | 230 |
GO:0051169110 | Esophagus | ESCC | nuclear transport | 230/8552 | 301/18723 | 6.04e-28 | 2.02e-25 | 230 |
GO:0006091110 | Esophagus | ESCC | generation of precursor metabolites and energy | 331/8552 | 490/18723 | 3.86e-23 | 8.45e-21 | 331 |
GO:0071496111 | Esophagus | ESCC | cellular response to external stimulus | 215/8552 | 320/18723 | 4.29e-15 | 2.43e-13 | 215 |
GO:0046034111 | Esophagus | ESCC | ATP metabolic process | 189/8552 | 277/18723 | 1.99e-14 | 1.04e-12 | 189 |
GO:0031668111 | Esophagus | ESCC | cellular response to extracellular stimulus | 168/8552 | 246/18723 | 4.93e-13 | 2.23e-11 | 168 |
GO:0031669110 | Esophagus | ESCC | cellular response to nutrient levels | 148/8552 | 215/18723 | 4.58e-12 | 1.76e-10 | 148 |
GO:0031667111 | Esophagus | ESCC | response to nutrient levels | 289/8552 | 474/18723 | 9.25e-12 | 3.47e-10 | 289 |
GO:007190016 | Esophagus | ESCC | regulation of protein serine/threonine kinase activity | 227/8552 | 359/18723 | 1.12e-11 | 4.10e-10 | 227 |
GO:0009267110 | Esophagus | ESCC | cellular response to starvation | 110/8552 | 156/18723 | 2.63e-10 | 7.37e-09 | 110 |
GO:004259419 | Esophagus | ESCC | response to starvation | 133/8552 | 197/18723 | 4.31e-10 | 1.14e-08 | 133 |
GO:005117014 | Esophagus | ESCC | import into nucleus | 111/8552 | 159/18723 | 5.69e-10 | 1.44e-08 | 111 |
GO:0006753110 | Esophagus | ESCC | nucleoside phosphate metabolic process | 288/8552 | 497/18723 | 1.80e-08 | 3.50e-07 | 288 |
GO:0019693111 | Esophagus | ESCC | ribose phosphate metabolic process | 234/8552 | 396/18723 | 4.24e-08 | 7.76e-07 | 234 |
GO:0009117111 | Esophagus | ESCC | nucleotide metabolic process | 282/8552 | 489/18723 | 4.70e-08 | 8.50e-07 | 282 |
GO:0009259111 | Esophagus | ESCC | ribonucleotide metabolic process | 224/8552 | 385/18723 | 4.41e-07 | 6.00e-06 | 224 |
GO:0072521111 | Esophagus | ESCC | purine-containing compound metabolic process | 238/8552 | 416/18723 | 1.20e-06 | 1.49e-05 | 238 |
GO:0009150111 | Esophagus | ESCC | purine ribonucleotide metabolic process | 213/8552 | 368/18723 | 1.40e-06 | 1.69e-05 | 213 |
GO:0006163111 | Esophagus | ESCC | purine nucleotide metabolic process | 226/8552 | 396/18723 | 2.81e-06 | 3.21e-05 | 226 |
GO:004586018 | Esophagus | ESCC | positive regulation of protein kinase activity | 219/8552 | 386/18723 | 6.91e-06 | 6.97e-05 | 219 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa04932210 | Esophagus | ESCC | Non-alcoholic fatty liver disease | 122/4205 | 155/8465 | 5.69e-14 | 1.59e-12 | 8.14e-13 | 122 |
hsa04714211 | Esophagus | ESCC | Thermogenesis | 163/4205 | 232/8465 | 9.22e-11 | 1.14e-09 | 5.86e-10 | 163 |
hsa040689 | Esophagus | ESCC | FoxO signaling pathway | 89/4205 | 131/8465 | 1.56e-05 | 7.98e-05 | 4.09e-05 | 89 |
hsa0415210 | Esophagus | ESCC | AMPK signaling pathway | 80/4205 | 121/8465 | 1.73e-04 | 6.67e-04 | 3.42e-04 | 80 |
hsa049109 | Esophagus | ESCC | Insulin signaling pathway | 89/4205 | 137/8465 | 1.97e-04 | 7.32e-04 | 3.75e-04 | 89 |
hsa04530211 | Esophagus | ESCC | Tight junction | 105/4205 | 169/8465 | 6.73e-04 | 2.23e-03 | 1.14e-03 | 105 |
hsa049318 | Esophagus | ESCC | Insulin resistance | 69/4205 | 108/8465 | 1.92e-03 | 5.54e-03 | 2.84e-03 | 69 |
hsa0421114 | Esophagus | ESCC | Longevity regulating pathway | 58/4205 | 89/8465 | 2.19e-03 | 6.16e-03 | 3.16e-03 | 58 |
hsa047105 | Esophagus | ESCC | Circadian rhythm | 24/4205 | 34/8465 | 1.09e-02 | 2.51e-02 | 1.29e-02 | 24 |
hsa0492214 | Esophagus | ESCC | Glucagon signaling pathway | 64/4205 | 107/8465 | 2.18e-02 | 4.80e-02 | 2.46e-02 | 64 |
hsa0493238 | Esophagus | ESCC | Non-alcoholic fatty liver disease | 122/4205 | 155/8465 | 5.69e-14 | 1.59e-12 | 8.14e-13 | 122 |
hsa04714310 | Esophagus | ESCC | Thermogenesis | 163/4205 | 232/8465 | 9.22e-11 | 1.14e-09 | 5.86e-10 | 163 |
hsa0406814 | Esophagus | ESCC | FoxO signaling pathway | 89/4205 | 131/8465 | 1.56e-05 | 7.98e-05 | 4.09e-05 | 89 |
hsa0415213 | Esophagus | ESCC | AMPK signaling pathway | 80/4205 | 121/8465 | 1.73e-04 | 6.67e-04 | 3.42e-04 | 80 |
hsa0491014 | Esophagus | ESCC | Insulin signaling pathway | 89/4205 | 137/8465 | 1.97e-04 | 7.32e-04 | 3.75e-04 | 89 |
hsa04530310 | Esophagus | ESCC | Tight junction | 105/4205 | 169/8465 | 6.73e-04 | 2.23e-03 | 1.14e-03 | 105 |
hsa0493113 | Esophagus | ESCC | Insulin resistance | 69/4205 | 108/8465 | 1.92e-03 | 5.54e-03 | 2.84e-03 | 69 |
hsa0421115 | Esophagus | ESCC | Longevity regulating pathway | 58/4205 | 89/8465 | 2.19e-03 | 6.16e-03 | 3.16e-03 | 58 |
hsa0471012 | Esophagus | ESCC | Circadian rhythm | 24/4205 | 34/8465 | 1.09e-02 | 2.51e-02 | 1.29e-02 | 24 |
hsa0492215 | Esophagus | ESCC | Glucagon signaling pathway | 64/4205 | 107/8465 | 2.18e-02 | 4.80e-02 | 2.46e-02 | 64 |
Page: 1 2 3 4 5 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PRKAG1 | SNV | Missense_Mutation | novel | c.395N>T | p.Gln132Leu | p.Q132L | P54619 | protein_coding | deleterious(0.02) | benign(0) | TCGA-44-7662-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
PRKAG1 | SNV | Missense_Mutation | novel | c.767N>G | p.Ile256Ser | p.I256S | P54619 | protein_coding | deleterious(0) | probably_damaging(0.946) | TCGA-21-1081-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
PRKAG1 | SNV | Missense_Mutation | novel | c.964N>T | p.Val322Leu | p.V322L | P54619 | protein_coding | tolerated(0.21) | benign(0.031) | TCGA-77-7337-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
PRKAG1 | SNV | Missense_Mutation | novel | c.788C>A | p.Thr263Asn | p.T263N | P54619 | protein_coding | deleterious(0.05) | benign(0.007) | TCGA-O2-A52W-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
PRKAG1 | SNV | Missense_Mutation | c.320A>G | p.Tyr107Cys | p.Y107C | P54619 | protein_coding | deleterious(0) | benign(0.428) | TCGA-HI-7170-01 | Prostate | prostate adenocarcinoma | Male | <65 | 6 | Unknown | Unknown | SD | |
PRKAG1 | SNV | Missense_Mutation | novel | c.656C>T | p.Thr219Ile | p.T219I | P54619 | protein_coding | deleterious(0.01) | benign(0.291) | TCGA-XK-AAIW-01 | Prostate | prostate adenocarcinoma | Male | >=65 | 9 | Unknown | Unknown | PD |
PRKAG1 | SNV | Missense_Mutation | novel | c.317G>A | p.Arg106His | p.R106H | P54619 | protein_coding | tolerated(0.06) | benign(0.006) | TCGA-R5-A7ZI-01 | Stomach | stomach adenocarcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
PRKAG1 | SNV | Missense_Mutation | novel | c.89N>A | p.Thr30Asn | p.T30N | P54619 | protein_coding | tolerated(0.09) | benign(0.191) | TCGA-VQ-A8PX-01 | Stomach | stomach adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
5571 | PRKAG1 | ENZYME, KINASE | METFORMIN | METFORMIN | 26471090 | |
5571 | PRKAG1 | ENZYME, KINASE | SAPONARIN | SAPONARIN | 26471090 | |
5571 | PRKAG1 | ENZYME, KINASE | metformin | METFORMIN | 22722338 |
Page: 1 |